OpenAI Invests in Healthcare AI with GPT-5 Launch

OpenAI has entered the healthcare sector, launching GPT-5 and the HealthBench platform to advance medical applications. Led by CEO Sam Altman, this initiative aims to revolutionize decision-making within healthcare. The GPT-5 model, renowned for its accuracy, has been validated through rigorous testing with physicians on real-world tasks and is supported by key partners like Amgen and Penda Health. Focus areas include developing GPT-5’s reasoning capabilities and conducting clinical trials to improve healthcare delivery.